SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $89.98 | 52-week high | $103.52 |
Prev. close | $88.34 | 52-week low | $63.80 |
Day low | $89.78 | Volume | 11,242,600 |
Day high | $91.70 | Avg. volume | 11,700,547 |
50-day MA | $92.06 | Dividend yield | 0.02% |
200-day MA | $82.73 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 6.57B |
Net Asset Value (NAV) | $88.45 |
Options? | Yes |
Total Holdings | 140 |
XBI Top Holdings
Symbol | Company | % of Total |
ALPN | ALPINE IMMUNE SCIENCES INC | 1.8% |
MRNA | MODERNA INC | 1.33% |
RVMD | REVOLUTION MEDICINES INC | 1.32% |
BPMC | BLUEPRINT MEDICINES CORP | 1.26% |
CRNX | CRINETICS PHARMACEUTICALS IN | 1.2% |
PTCT | PTC THERAPEUTICS INC | 1.17% |
UTHR | UNITED THERAPEUTICS CORP | 1.15% |
VKTX | VIKING THERAPEUTICS INC | 1.15% |
NTRA | NATERA INC | 1.14% |
XBI Price Returns
1-mo | 0.55% |
3-mo | 2.28% |
6-mo | 28.78% |
1-year | 5.41% |
3-year | -29.48% |
5-year | 2.92% |
YTD | 0.77% |
2023 | 7.60% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
2019 | 32.56% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |